Nia Therapeutics Patents

Patent portfolio assigned to Nia Therapeutics (verified via public assignee records). Estimated patent count: 1. US neurotech (founded 2018, out of DARPA RAM / Mike Kahana research); Smart Neurostimulation System (SNS), a closed-loop AI-guided 60-channel brain implant for memory loss after moderate-severe TBI; FDA Breakthrough Device Designation (2026). NeuroPace (RNS) and Medtronic (Percept DBS) cited as recording-channel comparators/competitors in Nia's own announcement. has_patents=true: US11305122B2 'Neuromodulation apparatus, method and system' originally assigned to Nia Therapeutics Inc (per Google Patents result; later reassigned to Cortera Neurotechnologies). patent_count_estimate=1 (only this one confirmed). No named customers (clinical-stage).